In early February, the EIKO, developed the vaccine jointly with the Barekat pharma group, with the intention to produce 14 million doses of the vaccine by summer.

According, to the official speaking on the sidelines of opening Iran's biggest portable hospital on Tuesday, the Middle Eastern country has an impeccable potential for the vaccine's mass production.

So far, Iran has launched clinical trials of three homegrown coronavirus vaccines.

In early February, Iran launched the COVID-19 inoculation campaign, using Russian-made Sputnik V, while the country is set to receive 16 million doses of COVID-19 vaccines through the World Health Organization-led COVAX international distribution initiative.

Additionally, they have plans to import more than 25 million doses from abroad, as well as produce 25 million other doses domestically.